Amphastar Pharmaceuticals Operating Cash Flow 2011-2026 | AMPH

Annual Operating Cash Flow Amphastar Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
156 M	213 M	184 M	89.2 M	98 M	57.3 M	41.8 M	38.2 M	39.2 M	38.6 M	10.7 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
213 M	10.7 M	87.8 M

Quarterly Operating Cash Flow Amphastar Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	35.1 M	-	-	-	55.3 M	-	-	-	40.4 M	-	-	53.6 M	50.8 M	-	-	55 M	22.8 M	-	40.4 M	31.6 M	1.48 M	-	36.1 M	48.1 M	-3.61 M	-	28.7 M	12.9 M	8.36 M	-	29.4 M	27 M	22.4 M	-	24.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
55.3 M	-3.61 M	31 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Precigen PGEN	-87.8 M	$ 3.1	-0.96 %	$ 758 M	USA
MorphoSys AG MOR	-481 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	-57.8 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-8.58 M	-	5.93 %	$ 314 M	Canada
Akero Therapeutics AKRO	-230 M	-	-	$ 3.67 B	USA
Akouos AKUS	-63.7 M	-	0.23 %	$ 488 M	USA
I-Mab IMAB	-1.3 B	-	-	$ 866 M	China
Genfit SA GNFT	99.9 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	-108 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	-23.8 M	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-418 M	$ 220.9	2.49 %	$ 5 B	Danmark
Aileron Therapeutics ALRN	-22.3 M	-	10.36 %	$ 9.8 M	USA
Midatech Pharma plc MTP	-6.01 M	-	-18.52 %	$ 27.3 M	Britain
Applied Genetic Technologies Corporation AGTC	-65.7 M	-	-	$ 26.5 M	USA
AgeX Therapeutics AGE	-18 M	-	-10.17 %	$ 12.2 K	USA
Aptinyx APTX	-59.7 M	-	-39.0 %	$ 4.57 M	USA
Acorda Therapeutics ACOR	-14 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	-14.9 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	-92.5 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-30.3 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-29.5 M	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	-34.5 M	-	-	$ 7.46 M	Israel
Avenue Therapeutics ATXI	-9.03 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	-206 M	$ 1.33	0.76 %	$ 339 M	Britain
Atreca BCEL	-80.7 M	-	-11.76 %	$ 5.79 M	USA
BeiGene, Ltd. BGNE	1.13 B	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	-235 M	-	-	$ 546 M	USA
ProQR Therapeutics N.V. PRQR	-26 M	$ 1.58	6.04 %	$ 99.5 M	Niderland
BioDelivery Sciences International BDSI	41 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	-92.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-75.6 M	-	-	$ 3.74 B	USA
Aeglea BioTherapeutics AGLE	-169 M	-	-	$ 1.01 B	USA
Avid Bioservices CDMO	11 M	-	-	$ 789 M	USA
CureVac N.V. CVAC	-733 M	-	-	$ 867 M	Germany
Bellerophon Therapeutics BLPH	-17.8 M	-	-74.18 %	$ 955 K	USA
Corbus Pharmaceuticals Holdings CRBP	-64.5 M	$ 8.31	1.59 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	-345 M	$ 47.09	1.42 %	$ 4.23 B	Schweiz
Arbutus Biopharma Corporation ABUS	-39.6 M	$ 4.53	5.1 %	$ 868 M	Canada
AIkido Pharma AIKI	-15.1 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	-116 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	-4.34 M	-	-5.38 %	$ 6.06 M	USA
CytomX Therapeutics CTMX	-75.6 M	$ 4.22	-0.47 %	$ 582 M	USA
Allena Pharmaceuticals ALNA	-45.7 M	-	3.16 %	$ 1.9 M	USA
Calithera Biosciences CALA	-66.3 M	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	-43.8 M	-	-	$ 2.17 B	USA
Cyclacel Pharmaceuticals CYCC	-7.99 M	-	-5.98 %	$ 34.1 M	USA